Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more.

    Ludipress® LCE

    Ludipress® LCE is a ready-to-use direct compression solution for lozenges, chewables and effervescent tablet. The white, free-flowin granulate that means quicker, easier, and more cost-effective tableting. With Ludipress® LCE, you save precious time on developing, analyzing and blending. You simply add your active ingredient, a lubricant, and compress your tablets. It is that easy.

    Ludipress® LCE means less effort, lower costs, and higher quality for lozenges, chewables, sublingual or effervescent tablets and modified release formulations. Ludipress® LCE does – in contrast to Ludipress® – not contain the disintegrant Kollidon® CL. Ludipress® LCE is therefore completely water-soluble and particularly suitable for the cost saving direct compression of processing. It enables direct compression of the majority of tablets that do not require a disintegrant. Like Ludipress®, Ludipress® LCE is a granulate that forms a homogenous mixture with the active ingredient – saving you development and analysis costs, and enabling you to quickly achieve the perfect formulation. When disintegrant Kollidon® CL is admixed, Ludipress® LCE is also suitable for all other kinds of tablets. When combined with an additional dry binder in the shape of Kollidon® VA 64, Ludipress® LCE can also be employed for high-dosage formulations.

    Ludipress® LCE – enabling efficient direct tablet manufacturing
    Streamlines the production process, reducing complexity and effort like no other direct-tableting excipient
    Completely water-soluble
    Outstanding binding power
    Excellent flowability and ideal particle size distribution
    Produces tablets of exceptional hardness
    Accelerates product development

    Ludipress® LCE composition

    96.5% Lactose + 3.5% Kollidon® 30

    The result: a granulate comprising carrier and filler as well as a tried and tested Povidone binder, with superior binding power.

    How direct compression with Ludipress® saves you time and money.

    Cut development time.

    With Ludipress® LCE, you can minimize the development effort associated with a new tablet. All components comply with the leading pharmacopoeias – giving you guaranteed quality from the very outset.

    Reduced process steps.

    You no longer have to weigh individual components, and blend them yourself. Ludipress® LCE forms homogenous mixtures with the active ingredient with ease and speed. Simply add your active ingredient to Ludipress® LCE – its excellent flowability means quick and uniform distribution. Add your lubricant, and compress your tablets. It is as easy as that.

    Ludipress® LCE

    The ideal mixture.

    Ludipress® LCE is greater than the sum of its individual parts: It is a formulated blend of excipients, creating a high-quality, ready-to-use granulate.

    Fast release of active ingredients.

    Although manufactured by direct compression, the tablets demonstrate exceptionally low friability.

    Due to the absence of the disintegrant Kollidon® CL, Ludipress® LCE is completely soluble in water.

    Technical Information

    Ludipress® LCE - Technical Information

    Lactose-based direct compression excipient

    Product Overview

    Focusing on your needs with platform solutions

    This brochure presents an overview of our leading-edge products, grouped in the following platforms: Instant and Modified Release, Solubilization, Skin Delivery and Softgels.

    Brochure

    Lupipress® and Ludipress® LCE - The quickest route to direct tableting

    Ludipress® LCE is ideal for lozenges, chewables, effervescent tablets and modified-release formulations; Ludipress® is suitable for low-dosage active ingredients. Both products are based on extensive research and development, aimed at creating excipients that enable faster, more efficient manufacturing – while delivering perfect results every time.

    Formulation

    Direct compression of effervescent tablets

    This formulation concept effectively combines direct compression, quick dissolution and high strength & low friability of the tablet.

    Formulation

    Direct compression of sustained release tablets

    This formulation concept effectively combines direct compression with high strength & low friability of tablets.

    Application Guide

    Pharmaceutical Technology of BASF Excipients

    This book describes the wide range of applications and functions of the excipients manufactured by BASF SE for the pharmaceutical industry. The spectrum of applications is remarkably broad, as can already be seen from the list of contents. It covers many fields of application in solid dosage forms such as instant-release and controlled-release tablets, applications in liquid dosage forms as solutions, suspensions and dry syrups, as well as many functions in semisolid dosage forms. The 3rd edition was actualized and revised by the inclusion of new excipients such as Kollicoat® IR grades, Kollidon® CL-F, Kollidon® CL-SF, Kollidon® VA 64 Fine and Ludiflash®, by the inclusion of new technologies such as melt extrusion and of several new formulations.

    Formulation

    Direct compression of lozenges

    This formulation concept effectively combines direct compression, high strength & low friability and benefits through lozenges.